ADMA Biologics, Inc. (ADMA) vs Alamar Biosciences, Inc. (ALMR)

A side-by-side comparison of ADMA Biologics, Inc. and Alamar Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
ADMA Biologics, Inc. logo
ADMA
ADMA Biologics, Inc.
$2.34B
$10.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Alamar Biosciences, Inc. logo
ALMR
Alamar Biosciences, Inc.
$2.64B
$38.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ADMA vs ALMR

growth of $100 · dividends reinvested · last 1y
ADMA -5.1% (-5.1%/yr)ALMR +73.3% (+73.3%/yr)ALMR compounded faster over this window
80100120140160180Start $100$95$173
ADMA ALMR

ADMA vs ALMR: by the numbers

  • •ALMR is the larger company ($2.64B vs $2.34B market cap).
  • •ADMA is profitable (32.98% net margin) while ALMR runs a net loss (-40.18%).

Metrics side by side

Valuation

MetricADMAALMR
P/E ratio14.44N/A
Forward P/E12.69N/A
P/S ratio4.57N/A
P/B ratio5.748.45
EV / EBITDA10.67N/A
FCF yield4.97%N/A

Profitability

MetricADMAALMR
Gross margin64.71%56.20%
Operating margin42.26%-42.22%
Net margin32.98%-40.18%
ROE41.39%N/A
ROIC27.60%-26.95%

Growth (annualized)

MetricADMAALMR
Revenue CAGR (5Y)54.55%N/A
Total return CAGR (5Y)54.74%N/A

Frequently asked

Is ADMA or ALMR more profitable?
ADMA runs the higher net margin — ADMA at 32.98% versus ALMR at -40.18%.

Go deeper

Full ADMA analysisFull ALMR analysisInteractive comparison tool

Dig into the metrics

ADMA Biologics P/E ratioADMA Biologics ROEAlamar Biosciences ROEADMA Biologics operating marginAlamar Biosciences operating marginADMA Biologics revenue growthAlamar Biosciences revenue growthADMA Biologics free cash flowAlamar Biosciences free cash flow

ADMA Biologics & Alamar Biosciences appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.